NO20023135L - <gamma>-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne - Google Patents

<gamma>-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne

Info

Publication number
NO20023135L
NO20023135L NO20023135A NO20023135A NO20023135L NO 20023135 L NO20023135 L NO 20023135L NO 20023135 A NO20023135 A NO 20023135A NO 20023135 A NO20023135 A NO 20023135A NO 20023135 L NO20023135 L NO 20023135L
Authority
NO
Norway
Prior art keywords
gamma
ifn
aerosol
solution
aqueous
Prior art date
Application number
NO20023135A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023135D0 (no
Inventor
Peter Van Vlasselaer
Woodruff J Emlen
Original Assignee
Intermune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Inc filed Critical Intermune Inc
Publication of NO20023135D0 publication Critical patent/NO20023135D0/no
Publication of NO20023135L publication Critical patent/NO20023135L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
NO20023135A 1999-12-30 2002-06-27 <gamma>-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne NO20023135L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17392699P 1999-12-30 1999-12-30
PCT/US2000/042831 WO2001049260A2 (en) 1999-12-30 2000-12-22 Y-ifn liquid-droplet aerosol and method

Publications (2)

Publication Number Publication Date
NO20023135D0 NO20023135D0 (no) 2002-06-27
NO20023135L true NO20023135L (no) 2002-08-23

Family

ID=22634096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023135A NO20023135L (no) 1999-12-30 2002-06-27 <gamma>-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne

Country Status (18)

Country Link
US (1) US20010043906A1 (xx)
EP (1) EP1286658B1 (xx)
JP (1) JP2003519169A (xx)
KR (1) KR20020072563A (xx)
CN (1) CN1230197C (xx)
AT (1) ATE319424T1 (xx)
AU (1) AU4525801A (xx)
BR (1) BR0016884A (xx)
CA (1) CA2395803A1 (xx)
CZ (1) CZ20022220A3 (xx)
DE (1) DE60026618T2 (xx)
HK (1) HK1052876B (xx)
MX (1) MXPA02006518A (xx)
NO (1) NO20023135L (xx)
NZ (1) NZ519773A (xx)
PL (1) PL356817A1 (xx)
WO (1) WO2001049260A2 (xx)
ZA (1) ZA200205167B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6883516B2 (en) * 2000-04-27 2005-04-26 Chrysalis Technologies Incorporated Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6964761B1 (en) * 2001-12-12 2005-11-15 New York University Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ
DE10218328A1 (de) * 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US6830744B2 (en) * 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon
US20040235308A1 (en) 2003-05-22 2004-11-25 Dainippon Screen Mfg. Co., Ltd. Substrate treatment method and sustrate treatment apparatus
JP2007537274A (ja) * 2004-05-10 2007-12-20 ナステック ファーマスーティカル カンパニー インク． 副甲状腺ホルモンの粘膜送達を増強するための組成物及び方法
US8105572B2 (en) * 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
US20070065367A1 (en) * 2005-09-20 2007-03-22 Rany Condos Method of treating pulmonary disease with interferons
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US8105571B2 (en) 2005-09-20 2012-01-31 New York University Method of treating pulmonary disease with interferons
KR20130110225A (ko) * 2005-09-20 2013-10-08 뉴욕 유니버시티 인터페론을 사용하여 폐질환을 치료하는 방법
WO2008143892A1 (en) * 2007-05-18 2008-11-27 New York University Method of treating tuberculosis with interferons
US8557485B2 (en) * 2008-12-11 2013-10-15 GM Global Technology Operations LLC Tungsten-containing hydrogen-storage materials for anodes of PEM fuel cells
JP2012193207A (ja) * 2012-07-13 2012-10-11 New York Univ インターフェロンを用いる肺疾患の処置方法
WO2016169571A1 (en) * 2015-04-20 2016-10-27 Ghaleb Haider Abbas Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection
CN113491807B (zh) * 2020-04-03 2023-07-28 深圳麦克韦尔科技有限公司 一种气溶胶产生装置
CN116251174B (zh) * 2022-12-23 2023-09-29 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779221D1 (de) * 1986-08-19 1992-06-25 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
US5855564A (en) * 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism

Also Published As

Publication number Publication date
WO2001049260A3 (en) 2002-02-07
CN1230197C (zh) 2005-12-07
MXPA02006518A (es) 2004-07-30
CA2395803A1 (en) 2001-07-12
WO2001049260A2 (en) 2001-07-12
AU4525801A (en) 2001-07-16
ZA200205167B (en) 2003-11-05
NO20023135D0 (no) 2002-06-27
NZ519773A (en) 2005-02-25
HK1052876B (zh) 2006-06-16
US20010043906A1 (en) 2001-11-22
EP1286658A2 (en) 2003-03-05
EP1286658B1 (en) 2006-03-08
BR0016884A (pt) 2002-10-01
CZ20022220A3 (cs) 2003-01-15
DE60026618T2 (de) 2007-01-18
CN1434701A (zh) 2003-08-06
HK1052876A1 (en) 2003-10-03
ATE319424T1 (de) 2006-03-15
DE60026618D1 (de) 2006-05-04
KR20020072563A (ko) 2002-09-16
JP2003519169A (ja) 2003-06-17
PL356817A1 (en) 2004-07-12

Similar Documents

Publication Publication Date Title
NO20023135L (no) &lt;gamma&gt;-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne
DE69832070T2 (de) Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
Lopez-Valpuesta et al. Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats
GEP20043259B (en) Device for Delivery of Aerosolized Active Agent to the Lung of a Human Patient
ATE200025T1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
ES2196055T3 (es) Dispositivo transdermico que contiene polivinilpirrolidona como intensificador de la solubilidad.
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
WO1989007959A1 (en) Occlusive body for administering a physiologically active substance
RU94040361A (ru) Аэрозольная фармацевтическая композиция, баллончик для доставки композиции, дозировочный ингалятор, способ лечения респираторных заболеваний, способ получения композиции
DE69925936D1 (de) Vorrichtung zur lokalen verabreichung einer arznei in einer körperhöhle
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
EP1576978A3 (en) Device for administering insulin in controlled dosages by controlling total inhaled volume
EP1138275A3 (en) Multiple solution dental irrigator
CA2193129A1 (en) Transdermal drug delivery system
TNSN99038A1 (fr) Livraison d&#39;un agent actif atomise
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
NZ501950A (en) Medicinal compositions for application to mucosa
CA2270286A1 (en) Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
AU645023B2 (en) Compositions and method for treating painful, inflammatory or allergic disorders
DE60028367D1 (de) Oligonukleotide die eine antisense-sequenz enthalten die durch eine sekondärstruktur stabilisiert sind und pharmazeutische zusammensetzungen die sie enthalten
HRP960230B1 (en) Fluorophenyl substituted alkenyl carboxylic acid guanidines, processes for their preparation, their use as medicinal or diagnostic agent as well as medicaments containing them
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
EP1450739A1 (en) Hydrating nasal gel and applicator
Peplow et al. An intrauterine silastic system for the sustained release of indomethacin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application